Rennova Health Inc (RNVA)
0.0000
0.00 (0.00%)
USD |
OTCM |
Apr 24, 15:53
Rennova Health Cash from Financing (TTM): 4.452M for Sept. 30, 2022
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2022 | 4.452M |
June 30, 2022 | 6.700M |
March 31, 2022 | 8.982M |
December 31, 2021 | 9.612M |
September 30, 2021 | 9.283M |
June 30, 2021 | 11.28M |
March 31, 2021 | 15.84M |
December 31, 2020 | 17.23M |
September 30, 2020 | 13.11M |
June 30, 2020 | 17.58M |
March 31, 2020 | 15.15M |
December 31, 2019 | 14.20M |
September 30, 2019 | 15.55M |
June 30, 2019 | 8.401M |
March 31, 2019 | 7.036M |
December 31, 2018 | 7.023M |
September 30, 2018 | 11.49M |
June 30, 2018 | 13.36M |
March 31, 2018 | 12.71M |
December 31, 2017 | 18.14M |
September 30, 2017 | 15.69M |
June 30, 2017 | 17.45M |
March 31, 2017 | 15.00M |
December 31, 2016 | 11.08M |
September 30, 2016 | 8.527M |
Date | Value |
---|---|
June 30, 2016 | |
March 31, 2016 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | 9.673M |
December 31, 2014 | 1.214M |
September 30, 2014 | 1.214M |
June 30, 2014 | 1.228M |
March 31, 2014 | -0.156M |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.452M
Minimum
Sep 2022
17.58M
Maximum
Jun 2020
11.96M
Average
12.20M
Median
Cash from Financing (TTM) Benchmarks
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
IGC Pharma Inc | 2.856M |
NovaBay Pharmaceuticals Inc | 1.91M |
Protalix BioTherapeutics Inc | 24.67M |